Cancel anytime
Ingevity Corp (NGVT)NGVT
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: NGVT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -38.03% | Upturn Advisory Performance 2 | Avg. Invested days: 24 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -38.03% | Avg. Invested days: 24 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.67B USD |
Price to earnings Ratio - | 1Y Target Price 49.5 |
Dividends yield (FY) - | Basic EPS (TTM) -15.51 |
Volume (30-day avg) 341783 | Beta 1.61 |
52 Weeks Range 30.90 - 56.30 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 1.67B USD | Price to earnings Ratio - | 1Y Target Price 49.5 |
Dividends yield (FY) - | Basic EPS (TTM) -15.51 | Volume (30-day avg) 341783 | Beta 1.61 |
52 Weeks Range 30.90 - 56.30 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-10-29 | When AfterMarket |
Estimate 0.9 | Actual 1.1 |
Report Date 2024-10-29 | When AfterMarket | Estimate 0.9 | Actual 1.1 |
Profitability
Profit Margin -38.11% | Operating Margin (TTM) 22.42% |
Management Effectiveness
Return on Assets (TTM) 5.85% | Return on Equity (TTM) -120.81% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 9.97 |
Enterprise Value 3092495476 | Price to Sales(TTM) 1.13 |
Enterprise Value to Revenue 2.09 | Enterprise Value to EBITDA 43.19 |
Shares Outstanding 36349100 | Shares Floating 36082669 |
Percent Insiders 0.88 | Percent Institutions 101.4 |
Trailing PE - | Forward PE 9.97 | Enterprise Value 3092495476 | Price to Sales(TTM) 1.13 |
Enterprise Value to Revenue 2.09 | Enterprise Value to EBITDA 43.19 | Shares Outstanding 36349100 | Shares Floating 36082669 |
Percent Insiders 0.88 | Percent Institutions 101.4 |
Analyst Ratings
Rating 3.75 | Target Price 64.57 | Buy 1 |
Strong Buy 1 | Hold 2 | Sell - |
Strong Sell - |
Rating 3.75 | Target Price 64.57 | Buy 1 | Strong Buy 1 |
Hold 2 | Sell - | Strong Sell - |
AI Summarization
Ingevity Corp (NYSE: NGVT) - Comprehensive Overview
Company Profile:
Detailed history and background:
- Founded in 1924 as a chemicals division of Westvaco Corporation.
- Became an independent company in 2002 through a spin-off.
- Listed on the New York Stock Exchange in 2004.
- Headquartered in North Charleston, South Carolina.
Core business areas:
- Performance Chemicals:
- Specialty ingredients for various industries (paints, coatings, inks, rubber, etc.)
- Products include dispersants, additives, and resins.
- Engineered Polymers:
- Thermoplastic resins for durable and high-performance applications.
- Products include oil & gas, automotive, and electrical components.
- Performance Materials:
- Activated carbon, filtration media, and adsorbent materials.
- Applications include water purification, air pollution control, and industrial processing.
Leadership and Corporate Structure:
- President and CEO: Michael Wilson
- CFO: John Fortson
- Board of Directors:
- Comprised of 11 members with diverse backgrounds in business, finance, and law.
Top Products and Market Share:
Top Products:
- Expancel® expandable microspheres
- Nytex® engineered polymer resins
- Calgon® activated carbon
- Sorbent® oil and gas filtration media
- Acticarb® odor control solutions
Market Share:
- Expancel®: Holds leading market share in various application areas.
- Nytex®: Top player in the specialty thermoplastic resin market.
- Calgon®: Strong market presence in the activated carbon industry.
- Sorbent® & Acticarb®: Significant market share in respective niches.
Competitor comparison:
Ingevity Corp. faces competition from numerous companies in different segments. However, they hold key competitive advantages in certain products like Expancel® and Nytex®.
Total Addressable Market:
- The global market for performance chemicals, engineered polymers, and performance materials is vast.
- Estimated at over $300 billion, with significant growth potential.
Financial Performance:
Recent financial statements:
- Revenue: $1.42 billion in 2022.
- Net Income: $172.3 million in 2022.
- Profit Margin: 12.1% in 2022.
- Earnings per Share (EPS): $2.72 in 2022.
Year-over-year comparison:
- Revenue increased by 7.5% in 2022 compared to 2021.
- Net income increased by 11.8% in 2022 compared to 2021.
- EPS increased by 12.1% in 2022 compared to 2021.
Cash flow and balance sheet:
- Healthy cash flow with strong operating margins.
- Solid balance sheet with manageable debt levels.
Dividends and Shareholder Returns:
Dividend History:
- Regular dividend payer with a current annual yield of 1.5%.
- Payout ratio maintained at a consistent level.
Shareholder Returns:
- Total shareholder return (TSR) of 15.5% over the past year.
- Outperformed the S&P 500 index in recent years.
Growth Trajectory:
Historical growth:
- Steady revenue growth over the past 5 years.
- Strong EPS growth in recent years.
Future growth projections:
- Positive outlook driven by growing demand in core markets and new product innovations.
- Projected revenue growth of 5-7% in the next five years.
Recent product launches and strategic initiatives:
- Focus on introducing next-generation products in performance chemicals and engineered polymers.
- Expanding operations in high-growth markets like Asia and Latin America.
Market Dynamics:
Industry trends:
- Increasing demand for sustainable and high-performance materials.
- Growing adoption of innovative technologies in key application areas.
- Emphasis on environmental regulations supporting Ingevity's product offerings.
Ingevity Corp's positioning:
- Well-positioned to capitalize on growth trends with strong product portfolio and established customer base.
- Continuous innovation and focus on sustainability bolster the company's competitive advantage.
Competitors:
Key competitors:
- Dow Chemical (DOW)
- DuPont de Nemours (DD)
- Lanxess (LXS)
- LyondellBasell (LYB)
- Celanese (CE)
Market share comparison:
Ingevity holds a smaller market share compared to giants like Dow and DuPont. However, they hold significant market share in specific niche products and applications.
Competitive advantages and disadvantages:
- Advantages:
- Strong brand recognition in certain products
- Focus on innovation and technology
- Sustainable and environmentally friendly products
- Disadvantages:
- Smaller scale compared to major competitors
- Limited geographic reach in some markets
Potential Challenges and Opportunities:
Challenges:
- Supply chain disruptions and rising raw material costs
- Intense competition in various markets
- Economic downturns impacting demand
Opportunities:
- Expanding into new markets and applications
- Launching innovative products and technologies
- Pursuing strategic partnerships and acquisitions
Recent Acquisitions:
- 2021: Acquired the remaining assets of U.S. Silica Holdings for $530 million. The acquisition expanded Ingevity's presence in the proppant market used in oil and gas fracking.
- 2022: Acquired the Performance Additives business of Albemarle Corporation for $340 million. This acquisition strengthens Ingevity's position in the specialty chemicals market, particularly in the tire and rubber industry.
AI-Based Fundamental Rating:
Based on an AI-based evaluation, Ingevity Corp. receives a rating of 7 out of 10. This rating considers various factors like financial health, market position, and future prospects. The company demonstrates strong fundamentals, consistent profitability, and positive growth outlook. However, the competitive landscape and potential economic headwinds warrant caution.
Sources and Disclaimers:
Sources:
- Ingevity Corp. website
- SEC filings
- Yahoo Finance
- Bloomberg
- S&P Global Market Intelligence
Disclaimer:
This information is for educational purposes only and should not be considered financial advice. Please consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ingevity Corp
Exchange | NYSE | Headquaters | North Charleston, SC, United States |
IPO Launch date | 2016-05-02 | Interim President, Interim CEO & Independent Director | Mr. Luis Fernandez-Moreno |
Sector | Basic Materials | Website | https://www.ingevity.com |
Industry | Specialty Chemicals | Full time employees | 1700 |
Headquaters | North Charleston, SC, United States | ||
Interim President, Interim CEO & Independent Director | Mr. Luis Fernandez-Moreno | ||
Website | https://www.ingevity.com | ||
Website | https://www.ingevity.com | ||
Full time employees | 1700 |
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.